awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35840886-9D13C491-029E-406C-BE21-041A0BD410DA
Q35840886-9D13C491-029E-406C-BE21-041A0BD410DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35840886-9D13C491-029E-406C-BE21-041A0BD410DA
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report
P2860
Q35840886-9D13C491-029E-406C-BE21-041A0BD410DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35840886-9D13C491-029E-406C-BE21-041A0BD410DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c64516cf7236f5edc06cf2a5d859364e8e3a6e70
P2860
Dasatinib: an anti-tumour agent via Src inhibition.